Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 294-585-1 | CAS number: 91744-23-9
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Imwitor 375 is an insoluble UVCB liquid with a low vapour pressure. There is no toxicokinetic data on Imwitor 375 itself, but it is composed of glycerides and glyceride citrate esters with a variety of fatty acid chain lengths and degrees of saturation/unsaturation. Glycerides are found naturally in foodstuff consumed by humans and animals and known to be absorbed following ingestion. However, fats are not absorbed by the skin because they are insoluble in water and therefore are unable to partition from the stratum corneum into the epidermis. There is no data available for the distribution of the UVCB in the body, however it is likely that the breakdown products would be distributed widely given that they contribute to the metabolic/physiological pathways involved in energy production, e.g. Kreb’s cycle. Glyceride citrate esters are likely to be broken down in the gastrointestinal tract into citric acid/citrate and a partial glyceride. The latter would then undergo enzymatic hydrolysis to release fatty acids and glycerol. Bioaccumulation of fatty acids takes place, if their intake exceeds the caloric requirements of the organism. Glycerol can be re-esterified to form endogenous triglycerides, metabolised and/or excreted in the urine. Glycerides would be excreted as carbon dioxide and water following oxidative physiologic metabolism. Any glycerides that are not hydrolysed in the gastrointestinal tract are likely to be excreted in the faeces.
Key value for chemical safety assessment
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
